Mosaic Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,250
Closed -$204K – 136
2026
Q2
$204K Buy
+2,250
New +$188K 0.13% 131
2026
Q1
– Sell
-2,381
Closed -$203K – 130
2025
Q4
$203K Buy
+2,381
New +$195K 0.14% 125
2024
Q3
– Sell
-2,522
Closed -$233K – 129
2024
Q2
$233K Buy
2,522
+70
+3% +$6.2K 0.17% 110
2024
Q1
$234K Buy
+2,452
New +$206K 0.19% 105

Other funds holding EW

Mosaic Financial Group's EW Position: Q3 2026 in Review

Mosaic Financial Group sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 2,250 shares — an estimated $204K sold.

Mosaic Financial Group first reported a position in EW in Q1 2024 and held it in 4 quarters. The position peaked at $234K in Q1 2024. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Mosaic Financial Group reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
  • Mosaic Financial Group sold 2,250 Edwards Lifesciences shares in Q3 2026, an estimated $204K.
  • Mosaic Financial Group first reported a position in Edwards Lifesciences in Q1 2024 and held it in 4 quarters.
  • Mosaic Financial Group's Edwards Lifesciences position peaked at $234K in Q1 2024.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Mosaic Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.